Medpace Voice

Medpace Biorepository, a CAP accredited facility, is a key component of Medpace Central Labs and the full-service model.

Medpace is pleased to announce the addition of three scientists to our Central Laboratory leadership team.

As part of our efforts to expand laboratory services and capabilities, specifically in Asia, Medpace has relocated our central laboratory facilities from Beijing to Shanghai.…

We sat down with Christopher Daniels, Director, Clinical Laboratory Services at Medpace, to discuss regulations and standards for biomarkers, validation process for central labs, and…

In a process-oriented industry that breathes deeply from a standard set of regulations, it is easy to see the importance of each storage unit in…

As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory…

As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…

Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.

While the CRO industry has grown primarily through mergers and acquisitions, Medpace has expanded through disciplined organic growth – expanding globally to operations in 36…

Experts from Medpace’s central laboratory evaluated the effect of hemolysis, icterus and lipemia on chemistry assays and assessed the association between the amount of interfering…